Product image of Lipomeg (Omega-3-Acid Ethyl Esters 90) supplied by GNH India

Lipomeg

Active Ingredient:
Omega-3-Acid Ethyl Esters 90
Origin:
EU

Lipomeg (Omega-3-Acid Ethyl Esters 90)

Omega-3-Acid Ethyl Esters, the active ingredient in Lipomeg, is a omega-3 fatty acid presented as an oral formulation for oral use. It is used to lower elevated plasma triglyceride concentrations in patients with severe hypertriglyceridaemia.

GNH India supplies Lipomeg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Strides Pharma (Cyprus) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lipomeg is an omega‑3 fatty acid medication that targets elevated triglyceride metabolism.

  • Severe hypertriglyceridaemia: reduces plasma triglyceride levels to lower the risk of pancreatitis.
  • Familial hyperchylomicronaemia: assists in managing extremely high triglycerides when diet alone is insufficient.
  • Adjunct to lipid‑lowering therapy: complements statins or fibrates to improve overall lipid profile.

How It Works

  • Omega-3-Acid Ethyl Esters are metabolised to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These fatty acids inhibit hepatic very‑low‑density lipoprotein (VLDL) synthesis and enhance the catabolism of triglyceride‑rich lipoproteins, resulting in a net reduction of circulating triglycerides.

Side Effects

Lipomeg may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Fish‑oil aftertaste: a persistent marine taste in the mouth.
  • Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort.
  • Diarrhoea: loose stools occurring after dosing.
  • Flatulence: increased intestinal gas.
  • Headache: mild to moderate pain.
  • Elevated liver enzymes: mild transaminase rise.

Serious or Rare Side Effects

  • Acute pancreatitis: severe abdominal pain requiring medical attention.
  • Bleeding complications: especially when combined with anticoagulants.
  • Allergic reactions: rash, pruritus, or anaphylaxis.
  • Atrial fibrillation: new‑onset irregular heart rhythm.
  • Severe hepatic injury: marked elevation of liver function tests.
  • Hyperglycaemia: increased blood glucose levels in susceptible individuals.

Precautions & Warnings

Before starting Lipomeg, clinicians should consider several safety measures.

  • Baseline triglyceride assessment: confirm severe hypertriglyceridaemia.
  • Liver function monitoring: check transaminases periodically.
  • Bleeding risk evaluation: review concurrent anticoagulant or antiplatelet therapy.
  • Fish‑oil allergy screening: avoid use in patients with known hypersensitivity.
  • Pregnancy and lactation counseling: discuss potential risks with the prescriber.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Lipomeg can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Warfarin: may potentiate anticoagulant effect and increase bleeding risk.
  • Antiplatelet agents (e.g., clopidogrel): additive bleeding tendency.
  • High‑dose fibrates: heightened risk of gallstone formation.

Moderate Interactions (Monitor Closely)

  • Statins: combined use may raise the chance of myopathy.
  • Other omega‑3 supplements: may lead to excessive omega‑3 exposure.
  • Cyclosporine: possible increase in serum triglyceride levels.

Frequently Asked Questions

Lipomeg contains omega‑3‑acid ethyl esters and is prescribed to lower markedly elevated triglyceride levels in patients with severe hypertriglyceridaemia, helping to reduce the risk of pancreatitis and improve overall lipid management.

The ethyl esters are hydrolysed to EPA and DHA, which suppress hepatic VLDL production and accelerate the clearance of triglyceride‑rich lipoproteins, leading to a net decrease in circulating triglycerides.

The appropriate dose of Lipomeg is determined by the prescribing clinician based on the patient’s triglyceride level, weight, and overall treatment plan. Dosage instructions are provided on the prescription label.

Safety data for Lipomeg in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing individuals.

To place an order, submit an enquiry on the Lipomeg product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lipomeg belongs to the omega‑3 fatty acid class, offering a different mechanism than fibrates or niacin. It specifically reduces VLDL synthesis, whereas fibrates activate PPAR‑α and niacin decreases hepatic VLDL secretion. Choice of therapy depends on patient profile, tolerance and co‑existing conditions.

Lipomeg should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability.

Lipomeg is taken orally, usually with meals to improve absorption and reduce gastrointestinal discomfort. The exact administration schedule is defined by the prescribing physician.

Serious adverse events include acute pancreatitis, significant bleeding especially when combined with anticoagulants, severe allergic reactions, and rare cases of atrial fibrillation. Patients should be monitored for these conditions and seek immediate medical attention if symptoms arise.

Lipomeg is contraindicated in individuals with a known allergy to fish oil or omega‑3 fatty acids, those with active bleeding disorders, and patients currently experiencing severe pancreatitis. Clinicians should also avoid prescribing it to patients with uncontrolled liver disease without careful assessment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omega-3-Acid Ethyl Esters 90

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT